North Star Investment Management Corp. Takes Position in Viemed Healthcare, Inc. $VMD

by · The Markets Daily

North Star Investment Management Corp. bought a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) in the 1st quarter, Holdings Channel.com reports. The firm bought 100,000 shares of the company’s stock, valued at approximately $921,000.

A number of other large investors have also bought and sold shares of VMD. State of Alaska Department of Revenue bought a new stake in Viemed Healthcare in the fourth quarter valued at approximately $25,000. Kemnay Advisory Services Inc. bought a new position in shares of Viemed Healthcare in the fourth quarter worth approximately $46,000. Quarry LP bought a new position in shares of Viemed Healthcare in the third quarter worth approximately $48,000. AQR Capital Management LLC bought a new position in shares of Viemed Healthcare in the first quarter worth approximately $90,000. Finally, SG Americas Securities LLC purchased a new position in shares of Viemed Healthcare in the fourth quarter worth $101,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Trading Down 2.1%

NASDAQ:VMD opened at $11.39 on Tuesday. The company has a fifty day moving average of $9.95 and a 200 day moving average of $8.88. Viemed Healthcare, Inc. has a 52 week low of $5.93 and a 52 week high of $11.88. The company has a quick ratio of 1.10, a current ratio of 1.22 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $436.66 million, a P/E ratio of 30.78 and a beta of 1.12.

Viemed Healthcare (NASDAQ:VMD – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%.The firm had revenue of $75.41 million during the quarter, compared to the consensus estimate of $74.40 million. On average, research analysts predict that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.

Insider Transactions at Viemed Healthcare

In related news, insider William Frazier sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the transaction, the insider owned 73,214 shares in the company, valued at $858,068.08. The trade was a 12.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Smokoff sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director directly owned 75,518 shares of the company’s stock, valued at $868,457. The trade was a 20.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 20.00% of the company’s stock.

Viemed Healthcare Profile

(Free Report)

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.

Featured Articles

Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report).